Future Market Insights (FMI), a leading market intelligence and consulting firm, forecasts a substantial growth trajectory for the Global Esophageal Implant Industry. According to their latest report, the market is projected to expand from US$ 147.0 million in 2023 to a noteworthy US$ 280.2 million by 2033, demonstrating a remarkable 6.7% Compound Annual Growth Rate (CAGR) over the next decade.

Several key factors are anticipated to fuel this significant market expansion. The rising prevalence of esophageal illnesses and the increasing preference for minimally invasive procedures are identified as primary drivers. As healthcare trends continue to evolve, the demand for advanced solutions like esophageal implants is expected to witness a substantial surge.

Technological advancements and continuous product innovation will also play a pivotal role in driving the adoption of esophageal implants. The market is likely to benefit from improved attributes such as enhanced biocompatibility, increased durability, ease of insertion, and enhanced patient comfort. These factors are poised to not only boost market share but also drive substantial sales growth.

Request a Sample of this Report Now!

Compliance with regulatory requirements and regulatory approvals are required for the commercialization and selling of esophageal implants. Companies that have gotten all of the relevant certifications and approvals have a competitive advantage and better sales.

Reimbursement policies and coverage for esophageal implants have an impact on sales since they affect patients’ access to and affordability of these devices. Favorable reimbursement regulations can boost esophageal implant acceptance and sales.

Because of variances in healthcare infrastructure, disease incidence, economic variables, and cultural factors, demand for esophageal implants varies among areas and countries. Companies may need to adjust their sales strategy to target various regional areas.

Global Esophageal Implant Industry Key Takeaways:

  • Global sales of esophageal implants are expected to surge at 7% CAGR through 2033.
  • Based on the product, the esophageal stents segment is forecast to progress at 0% CAGR from 2023 to 2033.
  • By application, the gastroesophageal reflux disease (GERD) segment is poised to exhibit 4% CAGR through 2033.
  • By end-use, the hospitals segment is anticipated to expand at a CAGR of 1% over the forecast duration.
  • The United States esophageal implant market value is likely to reach US$ 105.2 million by 2033.
  • The United Kingdom’s esophageal implant industry is estimated to reach a valuation of US$ 14.11 million by 2033.
  • Esophageal implant demand in China is expected to increase at 6% CAGR through 2033.
  • Japan’s market is predicted to reach a valuation of US$ 4.4 million by 2033.
  • South Korea’s esophageal implant industry is poised to exhibit a 9% CAGR during the forecast period.

Reach Out to Our Analyst For Your Queries

“Rising prevalence of esophageal disorders globally will create high demand for esophageal implants during the assessment period. To gain profits, manufacturers should focus on markets with favorable regulatory environments and operational guidelines.” – says a lead analyst at Future Market Insights (FMI)

Who is winning?

Leading manufacturers of esophageal implants include Boston Scientific, Medtronic, Cook Medical, Taewoong Medical., Micro-Tech (Nanjing) Co., Ltd., Ella-CS, M.I. Tech, Merit Medical, Xlumena Inc., Olympus Corporation, Johnson & Johnson, Apollo Endosurgery, Inc., EndoStim, NDO Surgical, Inc, Mederi Therapeutics, Becton Dickenson & Company, and Baxter International (Synovis Surgical Innovations) among other companies.

These key players are increasingly spending money on research and development activities to develop new products with better features. To fulfill shifting customer needs, they are also focusing on expanding their product line and bolstering their distribution networks.

Tactical alliances and connections with other firms are progressively popular in the sector, permitting participants to utilize one another’s strengths and broaden their influence in the marketplace.

Leading firms also adopt strategies such as mergers, partnerships, acquisitions, and collaborations to strengthen their position in the market and get access to new markets.

Global Esophageal Implant Industry Recent developments:

  • In 2020, Olympus started the commercial launch of the HANAROSTENT Esophagus TTS Stent.

More Insights Available:

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the Global Esophageal Implant Industry presenting historical data (2017 to 2022) and forecast statistics for the period from 2023 to 2033.

The study reveals future market projections based on the product (esophageal stents, magnetic sphincter augmentation (MSA) devices, injectable bulking agents, and artificial esophageal valves), application (gastroesophageal reflux disease (GERD), esophageal strictures, esophageal fistulas, esophageal defects, and weakened esophageal sphincters), and end-user (hospitals, ambulatory surgical centers, specialty clinics, academic & research institutions, and weakened esophageal sphincters) across various regions.

Request Your Customized Report Now!

Global Esophageal Implant Industry Segmentation:

By Product:

  • Esophageal Stents
    • Self-Expandable Metal Stents (SEMS)
    • Polymer Stents
    • Biodegradable Stents
    • Hybrid Stents
  • Magnetic Sphincter Augmentation (MSA) Devices
  • Injectable Bulking Agents
  • Artificial Esophageal Valves
    • Endoscopic Esophageal Valves
    • Prosthetic Esophageal Valves

By Application:

  • Gastroesophageal Reflux Disease (GERD)
  • Esophageal Strictures
  • Esophageal Fistulas
  • Esophageal Defects
  • Weakened Esophageal Sphincters

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic & Research Institutions
  • Weakened Esophageal Sphincters

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *